Ipha

Pharmaceutical companies in Ireland have called on Minister for Health Simon Harris to host a roundtable meeting to ensure the continued supply of med(...)

Big Pharma in Ireland has an image problem. At least that’s how it sees it. “I think we are not seen as a trusted partner,” says Aidan Lynch, presid(...)

The pharmaceutical industry is urging the Government to introduce “predictable multiannual budgeting” for breakthrough medicines in the budget process(...)

Prices across 750 medicines have fallen in a move that will save the Government €15 million on its drugs budget, according to the industry body Ipha. (...)

Irish patients are being denied access to nine drugs that are widely available across Europe, largely on cost grounds. The drugs – most of them cance(...)

Drug companies are increasingly frustrated at the Government’s failure to offer any assurances on clearing a logjam of new medicines that are waiting (...)

The full cost of the Government decision to approve cystic fibrosis drug Orkambi is beginning to be felt by the health service and patients less than (...)

The price of one of the world’s most popular drugs is falling 30 per cent in Ireland under the terms of a recently signed pricing agreement. Enbrel,(...)

Switching from a branded biologic drug to a cheaper “biosimilar” makes no meaningful difference to patients suffering from a series of chronic inflamm(...)

The Health Services Executive could lose out on savings of more than €50 million a year on just three widely used drugs under the terms of the new Med(...)